SREBF1 and neoplasm: Interestingly, in the Huh7-vector group, treatment with the SREBP1 inhibitor significantly suppressed tumor growth in orthotopic liver tumors (Fig. 9K–N) and subcutaneous tumors (Fig. 9O–Q) models.